SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Martek Biosciences---- future biotech cash cow!
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert Douglas who wrote (141)3/31/1998 3:48:00 PM
From: bill small  Read Replies (1) of 258
 
Abbott is so negative about using DHA for only only one reason---they would have to pay Martek for use of oil because they know it would give their competitors in the formula market a competitive advantage in the market which they would have to match. In other words, it would increase their cost of goods sold for formula and hence their margins would shrink somewhat--not good for balance sheet analysts.

They present lame technical reasons for not using DHA in public (they say it needs more study for proof of benefit/safety) but all the evidence of scientific study is contrary to their position.

hope this helps.......Bill
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News